Browsing Tag
Chimeric Therapeutics
3 posts
Chimeric Therapeutics reports early success in frontline cell therapy for AML in ADVENT-AML Phase 1B trial
Chimeric Therapeutics reports promising early results in its ADVENT-AML trial, with 2 of 3 patients showing remission. Find out how CHM is advancing cell therapy.
Chimeric Therapeutics secures new funding boost as cancer cell therapy trials accelerate
Discover how Chimeric Therapeutics' A$1M entitlement offer will drive innovation across CAR-T and NK cell therapy programs. Read the full story here.
Chimeric Therapeutics announces breakthrough AML response with CHM CORE-NK in Phase 1B trial
Chimeric Therapeutics has reported a significant milestone in its ongoing clinical trials, wherein a patient diagnosed with Acute…